Complete Genomics Garners the Prestigious 2023 R&D 100 Awards for Cutting-Edge Innovation

SAN JOSE, CALIFORNIA, 23 August, 2023- Complete Genomics, Inc., a pioneering genomic sequencing company, today proudly received the honor of the R&D 100 Awards from R&D World Magazine, often referred to as the “Oscars of Innovation”.

Proteomic study pinpoints potential biomarkers for long-COVID diagnosis and persistent health impacts

A two-year longitudinal study highlights proteomic changes in long-COVID patients, revealing potential biomarkers for diagnosis and shedding light on the persistent physiological challenges faced by

November 7, 2023

Nursing homes wield pandemic immunity laws to duck wrongful death suits

In early 2020, with reports of covid-19 outbreaks making dire headlines, Trever Schapers worried about her father’s safety in a nursing home in Queens.

May 14, 2024

Revolo advances plans to tackle eosinophilic esophagitis with orphan drug tag – Pharmaceutical Technology

Share this article Eosinophilic esophagitis can be triggered by a food allergy, acid reflux, or seasonal allergies. Credit: CGN089 via Shutterstock. Revolo Biotherapeutics plans to

January 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.